Bispecific Antibodies: A Playbook for Relapsed/Refractory Follicular Lymphoma
This program is supported by Genmab and AbbVie
3:00 p.m. - 6:00 p.m. Pacific time
ACCESS PROGRAM HERE
Marriott Marquis San Diego Marina
Marriott Grand Ballroom 11-13
On Demand program will be available here December 21, 2024.
Access Program Here
This live panel discussion will focus on the advancing field of bispecific antibodies in third-line relapsed/refractory follicular lymphoma. Experts in the field of follicular lymphoma, with the added perspective of a patient advocate, will review best practices for assessing and applying the latest data on bispecific antibodies, as well as strategies to enhance shared decision-making and patient-centered care.
Chair:
Joshua Brody, MD
Icahn School of Medicine at Mount Sinai
New York, NY
Speakers:
Krish Patel, MD
Director, Lymphoma Research, Sarah Cannon Research Institute
Nashville, TN
Lorna Warwick
Lymphoma Coalition
Mississauga, ON, CAN
Vikki Chavis
, Medscape
Email: vchavis@medscapelive.com